ConductScience.org, home

Paper7657517

Metalloproteinases in tumor progression: the contribution of MMP-9.

Himelstein BP and 4 others. Invasion Metastasis, 1994. Cited by 206 papers, by iCite.

Cite this record

ConductScience Library. Metalloproteinases in tumor progression: the contribution of MMP-9. Papers, record 7657517. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7657517

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metalloproteinases in tumor progression: the contribution of MMP-9.
PubMed
Journal
Invasion Metastasis
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
206
iCite
Relative citation ratio, by iCite
5.31
iCite
Revised in PubMed
2007-11-14
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Himelstein BPB P
2Canete-Soler RR
3Bernhard EJE J
4Dilks DWD W
5Muschel RJR J

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CollagenasesMajor topic
NeoplasmsMajor topic
Animals
Disease Progression
Humans
Matrix Metalloproteinase 9
Neoplasm Invasiveness
Neoplasm Metastasis

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 46830NCI NIH HHSUnited StatesR01CA046830PubMed and NIHNIH RePORTER
CA01718NCI NIH HHSUnited StatesK12CA001718PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 206 citations.

PMIDTitleJournalYearIn PapersSource
35681474The Outside-In Journey of Tissue Transglutaminase in Cancer.Cells2022https://conductscience.org/library/papers/35681474PubMed
33122890Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.Drug Des Devel Ther2020https://conductscience.org/library/papers/33122890PubMed
31807183Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets.Oncol Lett2019https://conductscience.org/library/papers/31807183PubMed
30008898Caspase-10, matrix metalloproteinase-9 and total laminin are correlated with the tumor malignancy of clear cell renal cell carcinoma.Oncol Lett2018https://conductscience.org/library/papers/30008898PubMed
28516983Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Chem Soc Rev2017https://conductscience.org/library/papers/28516983PubMed
27572907Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway.Mol Med Rep2016https://conductscience.org/library/papers/27572907PubMed
26450645IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.Oncotarget2015https://conductscience.org/library/papers/26450645PubMed
25279172Passive targeting of nanoparticles to cancer: A comprehensive review of the literature.Mol Clin Oncol2014https://conductscience.org/library/papers/25279172PubMed
24152909Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9.BMB Rep2013https://conductscience.org/library/papers/24152909PubMed
24102070Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft.Br J Pharmacol2013https://conductscience.org/library/papers/24102070PubMed
23912898Recruitment and retention: factors that affect pericyte migration.Cell Mol Life Sci2014https://conductscience.org/library/papers/23912898PubMed
23906232Effect of laminin 332 on motility and invasion in bladder cancer.Kaohsiung J Med Sci2013https://conductscience.org/library/papers/23906232PubMed
23566400Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer.J Transl Med2013https://conductscience.org/library/papers/23566400PubMed
23326116Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer.World J Gastroenterol2012https://conductscience.org/library/papers/23326116PubMed
23255946Piceatannol inhibits MMP-9-dependent invasion of tumor necrosis factor-α-stimulated DU145 cells by suppressing the Akt-mediated nuclear factor-κB pathway.Oncol Lett2013https://conductscience.org/library/papers/23255946PubMed
22207523Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells.J Cancer Res Clin Oncol2012https://conductscience.org/library/papers/22207523PubMed
21757928Optical imaging in cancer research: basic principles, tumor detection, and therapeutic monitoring.Med Princ Pract2011https://conductscience.org/library/papers/21757928PubMed
21721820Detection of enzyme activity in orthotopic murine breast cancer by fluorescence lifetime imaging using a fluorescence resonance energy transfer-based molecular probe.J Biomed Opt2011https://conductscience.org/library/papers/21721820PubMed
21616098Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains.Biochim Biophys Acta2011https://conductscience.org/library/papers/21616098PubMed
21340898Assessment of Gelatinases (MMP-2 and MMP-9 by Gelatin Zymography.Methods Mol Med2001https://conductscience.org/library/papers/21340898PubMed

See all 46 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTSS1520PubTator's text mininghttps://conductscience.org/library/genes/1520NCBI Gene
HPSE10855PubTator's text mininghttps://conductscience.org/library/genes/10855NCBI Gene
MMP94318PubTator's text mininghttps://conductscience.org/library/genes/4318NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7657517

GET https://conductscience.org/api/papers/v1/7657517/cited_by?page=2